Literature DB >> 12023589

Clear cell myomelanocytic tumor of the thigh: report of a unique case.

Andrew L Folpe1, Jesse K McKenney, Zhiming Li, Steven J Smith, Sharon W Weiss.   

Abstract

The clear cell myomelanocytic tumor (CCMMT) is a recently reported and very rare member of the perivascular epithelioid cell family of tumors (PEComa). All CCMMTs reported to date have occurred in or immediately adjacent to the falciform ligament/ligamentum teres. We report a case of CCMMT that occurred in the right thigh of a 43-year-old woman. Histologic examination showed the classic features of CCMMT, and immunohistochemical studies confirmed co-expression of smooth muscle actin, HMB-45, and microphthalmia transcription factor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12023589     DOI: 10.1097/00000478-200206000-00018

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  11 in total

Review 1.  [Perivascular neoplasms of skin and soft tissues. A review].

Authors:  T Mentzel
Journal:  Pathologe       Date:  2005-03       Impact factor: 1.011

2.  Perivascular epithelioid cell neoplasms (PEComas): four malignant cases expanding the histopathological spectrum and a description of a unique finding.

Authors:  Ilan Weinreb; David Howarth; Eleanor Latta; Danny Ghazarian; Runjan Chetty
Journal:  Virchows Arch       Date:  2007-02-15       Impact factor: 4.064

Review 3.  Cutaneous perivascular epithelioid cell tumors: A review on an infrequent neoplasm.

Authors:  Mar Llamas-Velasco; Luis Requena; Thomas Mentzel
Journal:  World J Methodol       Date:  2016-03-26

Review 4.  Primary perivascular epithelioid cell neoplasm (PEComa) of bone: report of two cases and review of the literature.

Authors:  Nicholas M Desy; Mitchell Bernstein; Ayoub Nahal; Mohamed Aziz; Samuel Kenan; Robert E Turcotte; Leonard B Kahn
Journal:  Skeletal Radiol       Date:  2012-07-03       Impact factor: 2.199

5.  Combination targeted therapy of VEGFR inhibitor, sorafenib, with an mTOR inhibitor, sirolimus induced a remakable response of rapid progressive Uterine PEComa.

Authors:  Fang Gao; Chengsuo Huang; Yiping Zhang; Ruirui Sun; Yujie Zhang; Huijun Wang; Shu Zhang
Journal:  Cancer Biol Ther       Date:  2016-03-30       Impact factor: 4.742

6.  "Malignant" perivascular epithelioid cell neoplasm: risk stratification and treatment strategies.

Authors:  Jonathan S Bleeker; J Fernando Quevedo; Andrew L Folpe
Journal:  Sarcoma       Date:  2012-04-26

Review 7.  PEComas: the past, the present and the future.

Authors:  Guido Martignoni; Maurizio Pea; Daniela Reghellin; Giuseppe Zamboni; Franco Bonetti
Journal:  Virchows Arch       Date:  2007-12-14       Impact factor: 4.064

8.  Perivascular epithelioid cell tumor (PEComa) of the uterine cervix associated with intraabdominal "PEComatosis": A clinicopathological study with comparative genomic hybridization analysis.

Authors:  Oluwole Fadare; Vinita Parkash; Yesim Yilmaz; M Rajan Mariappan; Linglei Ma; Denise Hileeto; Mazin B Qumsiyeh; Pei Hui
Journal:  World J Surg Oncol       Date:  2004-10-19       Impact factor: 2.754

9.  Malignant Perivascular Epithelioid Cell Neoplasm (PEComa) of the Pelvis: A Case Report.

Authors:  David D'Andrea; Esther Hanspeter; Carolina D'Elia; Thomas Martini; Armin Pycha
Journal:  Urol Case Rep       Date:  2016-03-18

10.  PEComa of the Upper Extremity: A Unique Case and Description of an Initial Response to Neoadjuvant Chemotherapy.

Authors:  D A Osei; F Alvandi; J S Brooks; C M Ogilvie
Journal:  Sarcoma       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.